Sign in / Join Now
ETFs & Funds
Made $7,000 on
today. Now that's a good day!!!
have never seen such an incredible surge like that in all of my trading days...incredible! Congrats!
Lazard Capital said with maximum U.S. revenue shares of
could be worth $83-$139/share
Add a reply...
Latest StockTalks »
people get SRPT breaking news and analysis by email alert.
Get email alerts on SRPT »
Sarepta Therapeutics, Inc.
Get latest price
From other sites
Sarepta Could More Than Double Its Addressable Market In A Few Years, But Eteplirsen Isn't The 'Be All End All'
at Benzinga (Thu, 9:28AM)
Catabasis Pharmaceuticals And Sarepta Therapeutics Announce A Joint Research Collaboration In Duchenne Muscular Dystrophy
at TheStreet (Thu, 8:00AM)
Sarepta Dosing First Patients In Phase 3 Trial Of Duchenne Muscular Dystrophy Drug
at Benzinga (Thu, 7:31AM)
Sarepta Therapeutics Announces First Patient Dosed In Phase III Clinical Trial Of SRP-4045 And SRP-4053 For The Treatment Of Duchenne Muscular Dystrophy Amenable To Exon 45 Or 53 Skipping
at TheStreet (Wed, 6:00PM)
Sarepta Therapeutics (SRPT) Stock Climbs, Analysts Bullish on Exondys
at TheStreet (Wed, 10:17AM)